The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 12th 2025
A new multicomponent vaccine, mRNA-1083, shows promise in enhancing immune responses against influenza and COVID-19, addressing vaccine hesitancy effectively.
AstraZeneca and Heptares Therapeutics enter agreement to develop novel immuno-oncology treatments
August 6th 2015AstraZeneca and Heptares Therapeutics announced that they have entered a licensing agreement which AstraZeneca will acquire exclusive rights to develop the adenosine A2A receptor antagonist, HTL-1071.
Read More
Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration
August 5th 2015Allergan plc and KYTHERA Biopharmaceuticals, Inc. today announced that they have amended and restated their merger agreement with respect to Allergan's pending acquisition of KYTHERA.
Read More